Risk for Secondary Primary Cancer Varies With Lymphoma Stage
Risk for SPMs differs over time for survivors of diffuse large B-cell lymphoma according to stage at diagnosis.
Risk for SPMs differs over time for survivors of diffuse large B-cell lymphoma according to stage at diagnosis.
Although reported absolute rates of second malignancies after radiotherapy for prostate cancer are very low, it is associated with higher rates of bladder, colon, and rectal cancers in patients who undergo radiotherapy for prostate cancer.